Stock listing

GPW:URT Urteste S.A. Akcje

Follow Urteste S.A. into a list and get an email when it puts out news.

Share price · GPW:URT

51.20 PLN +5.20 (+11.3%)

Close on Nov 20, 2026

Past year +24.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
46.00 – 52.80 PLNNov 20, 2026
Volume
1,877 sharesNov 20, 2026
Market cap
78.14M PLNAt the close on Nov 20, 2026 · price × 1.53M shares outstanding
52-week range
34.10 – 72.20 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
28,865 PLNMedian day 431 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Urteste S.A. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:URT · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
51.20+5.20+11.3%50.4052.8046.001,877
46.00+2.20+5.0%43.8046.5043.801,255
43.80+0.80+1.9%43.0044.0043.00257
43.000.000.0%43.0043.0042.00101
43.00+0.80+1.9%41.8044.6041.10780
42.20+0.60+1.4%42.1042.2039.90121
41.60-0.60-1.4%41.6042.2041.60125
42.20+1.20+2.9%40.9042.2040.9051
41.00-1.20-2.8%40.0041.0039.901,431
42.20+0.20+0.5%41.9042.2041.30585
42.00-0.10-0.2%42.2042.2041.90111
42.100.000.0%42.1042.1041.60830
42.10+1.10+2.7%42.0042.1042.004
41.00-1.00-2.4%42.2042.2041.00275
42.000.000.0%42.6042.6040.80152
42.00-0.50-1.2%42.4042.8040.80467
42.50-0.30-0.7%42.1042.7041.90808
42.80+0.10+0.2%42.7042.8042.70257
42.70+1.30+3.1%42.0042.9042.00214
41.40-0.90-2.1%42.0042.0040.10765
42.30+0.50+1.2%41.9042.3041.50205
41.80-1.00-2.3%42.8042.8041.80431
42.800.000.0%42.0042.8042.00291
42.80+1.10+2.6%41.5042.8041.50298
41.70-1.10-2.6%42.9042.9041.70143
42.800.000.0%42.9043.0041.80279
42.80+0.10+0.2%42.7043.5042.0093
42.700.000.0%42.7042.9042.001,044
42.70+0.10+0.2%41.5042.7041.50413
42.60-0.10-0.2%42.5042.7041.80554
42.70+0.50+1.2%42.2042.9041.40854
42.20+0.20+0.5%42.9043.1042.20524
42.00+0.20+0.5%42.7043.1040.601,361
41.80-0.40-0.9%43.1043.5040.206,687
42.20+0.20+0.5%41.5042.2041.00358
42.000.000.0%42.0042.0042.0044
42.00-0.20-0.5%42.2042.2041.5044
42.20-0.60-1.4%42.7042.7042.2040
42.800.000.0%42.8042.8042.801
42.80+0.50+1.2%42.3042.8042.3027
42.30+0.50+1.2%42.4042.8041.3048
41.80-0.80-1.9%41.6042.9041.50221
42.60+0.60+1.4%41.1043.4041.101,417
42.00-0.50-1.2%41.6044.0041.20794
42.500.000.0%42.4042.5040.60233
42.50-0.70-1.6%42.5042.5040.601,351
43.20-0.80-1.8%43.5043.5042.00517
44.00+0.50+1.1%43.6044.2042.001,539
43.50+1.00+2.4%43.3043.8042.50265
42.50-0.20-0.5%42.5044.4042.50556
42.70-0.30-0.7%43.1043.1040.8077
43.00+0.40+0.9%42.6043.1040.60548
42.60+0.30+0.7%42.4042.6041.00273
42.30+0.70+1.7%41.5042.4040.90704
41.60-1.40-3.3%42.1043.0041.60433
43.00-0.10-0.2%43.1043.1042.00967
43.10+0.10+0.2%42.0043.1042.00570
43.000.000.0%43.0043.4042.00282
43.000.000.0%44.1044.1043.00512
43.00-0.60-1.4%43.9043.9042.802,675
43.60-0.10-0.2%43.8043.8042.901,027
43.70+0.20+0.5%43.7043.7043.60197
43.50-0.30-0.7%43.0043.8043.001,495
43.80+0.50+1.2%44.0044.0043.001,688
43.30-0.20-0.5%44.4044.4043.301,068
Ticker
GPW:URT
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
GPW
Currency
PLN

What changed lately

Latest news

All Urteste S.A. news

Urteste S.A. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
2 in the last 12 months · 5 in all · newest Jul 1, 2026 · oldest 2024

Valuation

EV/sales 3,525× against a median of 2.9×: the highest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
77.55M PLN
P/E
Loss
EV/sales
3,525×
EV/EBITDA
Negative EBITDA
Price/book
3.5×
Gross margin
Revenue too small
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.0×
Beta
No index for this market yet

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Urteste S.A. · GPW:URTUS$19.24MUS$19.10Mn/a3,525×n/a3.5×n/a0.0×n/a
IVIM Technology, Inc. · KRX:460470US$20.68MUS$10.37Mn/a2.1×n/a1.1×−40.9%0.0×n/a
Q-linea AB · OMXSTO:QLINEAUS$20.66MUS$7.57Mn/a6.9×n/a0.9×n/a0.1×n/a
TFBS Bioscience, Inc. · TPEX:6939US$19.81MUS$7.83Mn/a1.3×n/a0.6×−38.6%0.0×n/a
SANIGEN Co., Ltd. · KRX:188260US$19.66MUS$10.06Mn/a2.2×n/a2.3×−82.6%0.1×n/a
NanoRepro AG · XETR:NN6US$19.45MUS$11.45Mn/an/an/a0.5×n/a0.0×n/a
Genematrix Inc. · KRX:109820US$19.06MUS$6.80Mn/a0.8×31.7×1.4×−1.7%0.0×n/a
Oxford BioDynamics PLC · LSE:OBDUS$18.46MUS$20.77Mn/a14.5×n/a4.3×n/a1.3×n/a
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALBUS$18.41MUS$16.94M1.1×3.6×61.6×0.3×367.8%0.0×n/a
Nexsen Limited · ASX:NXNUS$18.05MUS$15.08Mn/an/an/a4.8×n/a0.0×n/a
Genedrive PLC · LSE:GDRUS$17.85MUS$18.00Mn/a18.0×n/an/a−684.7%n/an/a
Median of the othersUS$19.25MUS$10.91M1.1×2.9×46.7×1.1×−39.7%0.0×

Team and board

Officers

OfficerRole
Christian PangratzChief Executive Officer

Board

DirectorRole
Grzegorz StefańskiMember of the Board
Tomasz KostuchMember of the Board

Financials

Annual, in PLN

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue22.0K1.80M1.33M3.00K000
Cost of revenue322.0K298.0K479.0K291.0K116.6K14.8K30.4K
Gross profit-322.0K1.50M-479.0K-288.0K-116.6K-14.8K-30.4K
Research and development2.19M2.58M5.55M2.59M1.45M977.0K
Selling, general and administrative865.0K969.0K1.22M1.38M1.35M565.9K254.5K
Operating income-8.53M-4.17M-6.45M-4.13M-4.19M-1.22M-364.7K
Depreciation and amortization322.0K439.0K776.0K437.0K64.0K14.8K797
EBITDA-8.21M-3.73M-5.67M-3.69M-4.12M-1.21M-363.9K
Interest expense205.0K545.0K570.0K51.0K165.67K18
Income before tax-5.94M-3.50M-5.42M-4.06M-4.20M-1.22M-364.7K
Income tax44.0K128.0K162.0K-37819
Net income-5.98M-3.63M-5.59M-4.06M-2.32M-530.2K-364.7K
Earnings per share, basic-4.24-2.58-4.32-3.58-2.21-0.89-0.61

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents8.84M1.46M1.14M3.43M8.53M427.3K173.3K
Short-term investments6.00M9.06M23.5M
Receivables5.73M7.38M1.70M1.05M1.38K10.1K
Inventory0162.0K86.0K7.20K690.7K78
Current assets20.6M17.9M26.6M4.58M9.19M1.32M251.8K
Property, plant and equipment585.2K64.8K
Total assets45.1M29.6M29.6M6.69M9.94M1.38M1.24M
Accounts payable312.0K841.0K371.0K415.0K230.0K8.90K38.5K
Current liabilities9.98M1.73M1.54M600.0K369.0K18.2K44.0K
Total debt2.98M415.0K627.0K597.0K710.0K
Total liabilities10.6M5.51M1.85M1.07M252.0K18.2K44.0K
Shareholders' equity24.9M24.1M27.7M5.62M9.69M674.3K1.20M
Shares outstanding1.41M1.41M1.29M1.14M1.05M595.2K595.2K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations10.6M-5.47M-5.32M-3.79M-2.57M-1.35M-398.5K
Capital spending-231.0K-8.96M-1.74M-1.19M-656.4K-42.2K-38.3K
Free cash flow10.4M-14.4M-7.07M-4.99M-3.23M-1.40M-436.7K
Cash from investing-9.41M6.23M-24.4M-1.19M-656.4K-42.2K-38.3K
Cash from financing6.15M-444.0K27.4M-113.0K11.3M1.65M610.0K
Change in cash7.38M322.0K-2.29M-5.10M8.11M254.1K173.3K

Open Financials

Cap table

Built by 6ix from Urteste S.A.’s releases

Common shares
1,526,080
Fully diluted
1,526,080

Fully diluted

LineShares
Common shares1,526,080

Share count over time

CountShares
Nov 22, 20261,526,080

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Christian PangratzChief Executive Officer · Since at least Nov 5, 2026
Grzegorz StefańskiMember of the Board · Since at least Jul 1, 2026
Tomasz KostuchMember of the Board · Since at least Jul 21, 2025

Open People

Log in to ask 6ix AI your own questions about Urteste S.A.